Calidi Biotherapeutics, Inc.
CLDI- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001855485
No open-market purchases or sales by Calidi Biotherapeutics, Inc. insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $89.3K in total; no superinvestor holds it.
Other share classesCLDWW
13F holders, Q2 2025
Institutional positions in Calidi Biotherapeutics, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q1 2025
- Shares held
- 2.86M
- −2.60M (−47.6%) vs. Q1 2025
- Total value
- $656.8K
- −$2.43M (−78.8%) vs. Q1 2025
- New holders
- 5
- 6 more added
- Sold out
- 6
- 6 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLDI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $89.3K |
| Q1 2026 | 28 | $478.8K |
| Q4 2025 | 27 | $524.7K |
| Q3 2025 | 22 | $353.6K |
| Q2 2025 | 35 | $656.8K |
| Q1 2025 | 36 | $3.09M |
| Q4 2024 | 33 | $1.27M |
| Q3 2024 | 20 | $363.4K |
| Q2 2024 | 32 | $523.2K |
| Q1 2024 | 31 | $1.56M |
| Q4 2023 | 25 | $3.29M |
| Q3 2023 | 13 | $3.54M |
| Q2 2023 | 25 | $40.6M |
| Q1 2023 | 27 | $45.8M |
| Q4 2022 | 25 | $39.6M |
| Q3 2022 | 21 | $36.1M |
| Q2 2022 | 42 | $214.8M |
| Q1 2022 | 40 | $202.4M |
| Q4 2021 | 27 | $184.1M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Calidi Biotherapeutics, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 792,000 | $182.2K | 0.01% | −2,530,000−76.2% | Reduced |
| Bank of Montreal | 422,500 | $97.2K | 0.00% | −67,300−13.7% | Reduced |
| Vanguard Group Inc | 353,380 | $81.3K | 0.00% | 00.0% | Unchanged |
| Belpointe Asset Management LLC | 249,833 | $57.5K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 232,576 | $53.5K | 0.00% | −19,340−7.7% | Reduced |
| HighTower Advisors, LLC | 119,471 | $27.5K | 0.00% | 00.0% | Unchanged |
| CPR Investments Inc. | 101,000 | $23.2K | 0.02% | 00.0% | Unchanged |
| Red Wave Investments LLC | 80,828 | $18.6K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 71,196 | $16.4K | 0.00% | +71,196 | New |
| State Street Corp | 61,290 | $14.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 48,693 | $11.2K | 0.00% | 00.0% | Unchanged |
| Drive Wealth Management, LLC | 45,000 | $10.3K | 0.00% | −10,000−18.2% | Reduced |
| UBS Group AG | 44,902 | $10.3K | 0.00% | +44,901+4,490,100.0% | Added |
| HRT Financial LP | 43,609 | $10.0K | 0.00% | +43,609 | New |
| Raymond James Financial Inc | 31,100 | $7.15K | 0.00% | +31,100 | New |
| Advisor Group Holdings, Inc. | 26,753 | $6.15K | 0.00% | +7,500+39.0% | Added |
| Delta Investment Management, LLC | 21,023 | $4.83K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 13,205 | $3.04K | 0.00% | +13,205 | New |
| Commonwealth Equity Services, LLC | 13,500 | $3.00K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 12,501 | $2.88K | 0.00% | 00.0% | Unchanged |
| Finepoint Capital LP | 12,499 | $2.88K | 0.00% | 00.0% | Unchanged |
| Avidian Wealth Solutions, LLC | 10,000 | $2.30K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 8,937 | $2.06K | 0.00% | +3,821+74.7% | Added |
| Virtu Financial LLC | 10,240 | $2.00K | 0.00% | −44,497−81.3% | Reduced |
| Grassi Investment Management | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 10,000 | $2.00K | 0.00% | +5,000+100.0% | Added |
| Evermay Wealth Management LLC | 6,342 | $1.46K | 0.00% | 00.0% | Unchanged |
| Barrett & Company, Inc. | 3,500 | $805 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,919 | $441 | 0.00% | −100−5.0% | Reduced |
| Tradewinds Capital Management, LLC | 1,000 | $230 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 560 | $129 | 0.00% | +260+86.7% | Added |
| CVA Family Office, LLC | 500 | $115 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 326 | $75 | 0.00% | +104+46.8% | Added |
| BlackRock, Inc. | 259 | $60 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 63 | $14 | 0.00% | +63 | New |
| RS Crum Inc. | 0 | $0 | 0.00% | −55,313−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −32,642−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,259−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −16,034−100.0% | Sold out |
| Apollo Management Holdings, L.P. | 0 | $0 | 0.00% | −12,500−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |